Insiders Medivir AB Deutsche Boerse AG

Equities

Delayed Deutsche Boerse AG Other stock markets 08:57:50 17/07/2024 BST			5-day change	1st Jan Change
0.22 ^EUR	-3.51%		-11.65%	+0.55%

06-27	Medivir AB Presents Positive New Data from Its Ongoing Phase Ib / IIa Study of Fostroxacitabine Bralpamide + Lenvima® in Advanced Hepatocellular Carcinoma	CI
06-20	Certain Shares of Medivir AB are subject to a Lock-Up Agreement Ending on 20-JUN-2024.	CI

Medivir Aktiebolag Approves Board Appointments	05-07	CI
Medivir AB Appoints Nomination Committee	23/10/23	CI
Medivir AB Announces Resignation of Anette Lindqvist as Director	20/10/23	CI
Medivir AB Announces Formation of A Scientific Advisory Council	07/08/23	CI
Medivir's New Chief Medical Officer Takes Office	21/02/23	MT
Medivir AB Appoints Pia Baumann as Chief Medical Officer	21/02/23	CI
Medivir Appoints Former AstraZeneca VP As Chief Medical Officer	21/11/22	MT
Medivir AB Appoints Pia Baumann as New Chief Medical Officer	21/11/22	CI
Medivir AB Appoints Nomination Committee	28/10/22	CI
Medivir Aktiebolag Announces Board Changes	05/05/22	CI
InDex Pharmaceuticals Names New Chief Development Officer, Chief Medical Officer	02/05/22	MT
Medivir's Newly Appointed CEO To Take Office	17/01/22	MT
Jens Lindberg Takes Office as CEO of Medivir AB on January 24	17/01/22	CI
Medivir AB Appoints Jenens Lindberg as New CEO	03/11/21	CI
Medivir AB Appoints Nomination Committee	28/10/21	CI
Medivir AB Appoints Jens Lindberg as CEO	25/10/21	CI
Medivir AB Announces Resignation of Helena Levander and Bengt Julander from Board of Directors	05/05/21	CI
Medivir AB Announces Executive Changes	16/04/21	CI
Medivir AB Announces the Resignation of Yilmaz Mahshid as CEO of the Company	22/03/21	CI
Medivir AB Appoints Tom Morris as Interim Chief Medical Officer	05/10/20	CI

No results for this search